Stem Cell - Market Insights, Competitive Landscape and Market Forecast–2027

Stem Cell - Market Insights, Competitive Landscape and Market Forecast–2027

Stem Cell Market By Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others), By Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries And Wounds, Cardiovascular Disorders, Others), By Therapy Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy), By Usage (Regenerative Medicine, Drug Discovery And Development), by geography is expected to grow at a steady CAGR forecast till 2026 owing to growing stem cell research activities and need for drug discovery

Global Stem Cell Market was valued at USD 14.37 billion in 2020, growing at a CAGR of 10.34% during the forecast period from 2021 to 2026 to reach USD 25.80 billion by 2026. The Stem Cell market is witnessing positive growth owing to the rising prevalence of various chronic diseases and the need for their drug discovery, growing stem cell research activities, increasing cases of genetic disorders, significant adoption of stem cell therapies globally. In addition, increasing demand for biologics, accumulative focus on developing advanced products in the arena are some of the factors contributing to the Global Stem Cell Market.

Stem Cell Market Dynamics:

The Stem Cell market is witnessing a growth in product demand owing to various reasons, one of the key factors being the rising prevalence of various chronic diseases and the significant need for their drug discovery. Cell transplantation as a therapy for neurodegenerative disorders such as Diabetes type 1, Parkinson's disease, and Alzheimer's disease among others are already being explored. For instance, in January 2022, the first patient in Canada has been dosed in a Phase 1 clinical trial of DA01, a cell-based investigational therapy for advanced Parkinson’s disease by BlueRock Therapeutics.

Based on the preclinical effect in these diseases, the technique is now being applied to other neurodegenerative disorders, such as AD, amyotrophic lateral sclerosis, and Huntington’s disease. According to WHO, by 2020, the prevalence of the chronic disease is predicted to increase by 57%. As the prevalence of chronic disease increases, people opting for stem cell-based treatment will rise, thus driving the market growth. Therefore, the prevalence of various chronic diseases and their research activities involved in drug development, in turn, would lead to an increase in demand for Stem Cell therapies in the forecast period (2021-2026), which will drive the Stem Cell market growth.

Another key factor responsible for the growth of the Stem Cell market is the increasing cases of genetic disorders. As genetic disorders occur due to anomalies of genetic origin, there has been a growing demand for stem cell therapies. Stem Cell therapy holds promise for treating a wide range of diseases, such as Cancer, Neonatal Encephalopathy, among others. For instance, on June 11, 2019, Mesoblast Limited announced it has expanded its partnership with JCR Pharmaceuticals Co. Ltd. in Japan for the use of mesenchymal stem cells (MSCs) in the treatment of newborns who lack sufficient blood supply and oxygen to the brain, a condition termed neonatal hypoxic-ischemic encephalopathy (HIE).

Hence, Stem Cell therapy-based biologics have a wide range of applications, from gene replacement to gene knockdown.

Furthermore, stem cell therapy offers a more sustainable treatment approach, thereby becoming one of the popular choices in the management of genetic diseases. This results in a large number of potential stem cell therapies being under clinical development. This indicates the plethora of potential therapies that may reach the market in the coming years. Hence, growing stem cell research activities is another key factor being responsible for further boosting the growth of the Stem Cell market during the forecast period.

Thus, all the aforementioned factors are expected to augment the global market for Stem Cell.

However, ethical issues related to the use of stem cells and the high cost of these therapies is likely to impede the market growth.

Along with the factors mentioned above, the COVID-19 pandemic presented another major opportunity for growth for the manufacturers operating in the biopharmaceutical domain. The effect of the pandemic accelerated the drug development activities for the SARS-Cov-2 virus across the globe. The dire need for developing a vaccine to contain the pandemic led to the approval and emergency use authorization of numerous vaccines for prophylactic use across the globe. Moreover, some of the recent studies have suggested that stem cell therapy has a remarkable effect on reducing mortality and morbidity of patients with COVID-19. Therefore, different candidates under development might prove as a potential therapy for COVID-19 infection.

Stem Cell Market Segment Analysis:

Stem Cell Market By Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others), By Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, Others), By Therapy Type (Allogeneic Stem Cell Therapy, Autologic Stem Cell Therapy), By Usage (Regenerative Medicine, Drug Discovery and Development), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the Therapy Type segment of the Stem Cell Market, Allogeneic Stem Cell Therapy is estimated to hold the highest share in the Stem Cell market during the forecast period (2021-2026).

Allogeneic Stem Cell Therapy offers several advantages as they are derived from a donor whose human leukocyte antigens (HLA) are acceptable matches to the patients. The stem cell donor may be related to the patient, or they may be an unrelated volunteer found through a donor registry.

Moreover, the growth of the segment is attributed to the easy process of manufacturing & production and the increasing availability of novel stem cell products across major countries.

Also, this therapy is widely used for treating different types of cancers such as lymphomas, leukemias, and myelomas.

Therefore, considering the advantages associated with Allogeneic Stem Cell Therapy, this product category is expected to generate significant revenue share eventually contributing to the overall growth of the global Stem Cell market in the forecast period.

North America is expected to dominate the overall Stem Cell Market:

Among all the regions, North America is expected to account for the largest share in the Global Stem Cell market. This can be ascribed to the high focus on therapy development for rare genetic diseases, growing stem cell research activities, a growing focus on the development of personalized medicines, supportive regulatory environment, sophisticated healthcare infrastructure, and increased awareness and product launches regarding new treatments are also expected to aid in the Stem Cell market growth in this region.

One of the key supporting factors for the growth of the North America Stem Cell market is the increasing focus on developing therapies for rare genetic diseases, particularly in the United States. As per the data provided by the US Food and Drug Administration (FDA) (2021), there are more than 7,000 rare diseases that affect more than 30 million people in the United States. The huge number of indications has resulted in a considerable number of companies in the country developing therapeutics aimed at treating genetic diseases. Therefore, the increasing focus of the US FDA and the US government in catering to the medical needs of people suffering from diseases in the country is also expected to drive the North America Stem Cell market in coming years.

Furthermore, an active pipeline by key players being involved in the development of such products is anticipated to fuel the market in the region.

Moreover, the occurrence of various strategic business activities in the region such as company collaborations, acquisitions, product launch, and approval, among others are also expected to propel the market for Stem Cell in the region. For instance, on March 12, 2019, Smith & Nephew plc announced its acquisition of Osiris Therapeutics, Inc., which is a company delivering regenerative medicine products, including skin, bone graft, and articular cartilage substitutes, for approximately USD 660 million. This in turn would provide a conducive growth environment for the North America region.

These kinds of products launched in the local markets will thereby push the product demand in the market. Therefore, the interplay of various factors in the region is expected to boost the North America Stem Cell market during the forecast period.

Stem Cell Market Key Players:

Some of the key market players operating in the Stem Cell market include Osiris Therapeutics, Inc. (Smith+Nephew Inc.), MEDIPOST Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd., JCR Pharmaceuticals Co. Ltd., NuVasive®, Inc., Stempeutics Research Pvt Ltd., Bristol-Myers Squibb Company, Organogenesis Inc., Takeda Pharmaceutical Company Limited, CHIESI SAS, Tegoscience, Biosolution Co., Ltd., CORESTEM, Inc., CO.DON, NIPRO and others.

Recent Developmental Activities in the Stem Cell Market:

• On 17 May 2021, MEDIPOST completed the expansion of its production facilities for its knee osteoarthritis stem cell products, CARTISTEM® and SMUP-IA-01, and will start to prepare for GMP (Good Manufacturing Practice) certification.
• On February 5, 2021, Bristol Myers won FDA approval for its cancer cell therapy, Breyanzi, for the treatment of late-stage lymphoma.
• In August 2020, Cipla Limited announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval from the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due to Buerger’s Disease and Atherosclerotic Peripheral Arterial Disease. It is the first allogeneic cell therapy product to be approved for commercial use in India and the first stem cell product to be approved globally for CLI treatment.

Key Takeaways from the Stem Cell Market Report Study

• Market size analysis for current Stem Cell market size (2020), and market forecast for 5 years (2021-2026)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Stem Cell market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the global Stem Cell market.
• Various opportunities available for the other competitor in the Stem Cell market space.
• What are the top performing segments in 2020? How these segments will perform in 2026.
• Which is the top-performing regions and countries in the current Stem Cell market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Stem Cell market growth in the coming future?

Target Audience who can be benefited from this Stem Cell Market Report Study

• Stem Cell products providers
• Research organizations and consulting companies
• Stem Cell-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in Stem Cell
• Various End-users who want to know more about the Stem Cell market and latest technological developments in the Stem Cell market.

Frequently Asked Questions for Stem Cell Market:

1. What is Stem Cell Therapy?

Stem cell therapy, also known as regenerative medicine, promotes the repair response of diseased, dysfunctional, or injured tissue using stem cells or their derivatives. It is the next step in organ transplantation and uses cells instead of donor organs, which are limited in supply.

2. What is the market for Global Stem Cell?

Global Stem Cell Market was valued at USD 14.37 billion in 2020, growing at a CAGR of 10.34% during the forecast period from 2021 to 2026 to reach USD 25.80 billion by 2026.

3. What are the drivers for Global Stem Cell Market?

The Stem Cell market is witnessing a positive market growth owing to the rising prevalence of various chronic diseases and the need for their drug discovery, growing stem cell research activities, increasing cases of genetic disorders, significant adoption of stem cell therapies globally. In addition, increasing demand for biologics, accumulative focus on developing advanced products in the arena.

4. Who are the key players operating in the Global Stem Cell Market?

Some of the key market players operating in the Stem Cell market include Osiris Therapeutics, Inc. (Smith+Nephew Inc.), MEDIPOST Co. Ltd., Anterogen Co. Ltd., Pharmicell Co. Ltd., JCR Pharmaceuticals Co. Ltd., NuVasive®, Inc., Stempeutics Research Pvt Ltd., Bristol-Myers Squibb Company, Organogenesis Inc., Takeda Pharmaceutical Company Limited, CHIESI SAS, Tegoscience, Biosolution Co., Ltd., CORESTEM, Inc., CO.DON, NIPRO, and others.

5. Which region has the highest share in the Stem Cell Market?

North America is expected to hold the highest share in the revenue in the Stem Cell market during the forecast period. This can be ascribed to the high focus on therapy development for rare genetic diseases, growing stem cell research activities, a growing focus on the development of personalized medicines, supportive regulatory environment, sophisticated healthcare infrastructure, and increased awareness and product launches regarding new treatments are also expected to aid in the Stem Cell market growth in this region.

Please Note: It will take 7-10 business days to complete the report upon order confirmation.